Scientific publications Choose Resource Type All Resource Types Abstract (1) Article (9) Poster (45) Presentation (6) Sort by year All Years 2025 (16) 2024 (11) 2023 (13) 2022 (5) 2021 (4) 2020 (2) 2019 (4) 2018 (1) 2017 (5) Search Publications November 2023 A First-in-Human Phase 1 Clinical Study Evaluating Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of the EDB+FN targeting ADC PYX-201 in Participants with Advanced Solid Tumors Poster Number: 762 SITC Poster September 2023 Quantitation of total antibody (tAb) from antibody drug conjugate (ADC) PYX-201 in rat and monkey plasma using an enzyme-linked immunosorbent assay (ELISA) and its application in preclinical studies (J Pharm Biomed Anal 2023 Sep 5:233:115452.) Article August 2023 Development and validation of a hybrid immunoaffinity LC–MS/MS assay for quantitation of total antibody (TAb) from an antibody drug conjugate (ADC) PYX-201 in human plasma (J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Aug 1:1228:123844.) Article July 2023 A sensitive and rapid LC-MS/MS assay for quantitation of free payload Aur0101 from antibody drug conjugate (ADC) PYX-201 in human plasma (J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Jul 15:1226:123786.) Article July 2023 A sensitive LC–MS/MS assay to quantitate free payload Aur0101 from ADC PYX-201 in rat and monkey plasma (Bioanalysis. 2023 Jul;15(14):833-843.) Article June 2023 A Phase 2 Trial with a Safety Lead-in to Evaluate the Addition of Sotigalimab, a CD40 Agonistic Monoclonal Antibody, to Standard-of-Care Doxorubicin for the Treatment of Advanced Sarcoma ASCO Poster May 2023 Bioanalysis of an antibody drug conjugate (ADC) PYX-201 in human plasma using a hybrid immunoaffinity LC–MS/MS approach (J Chromatogr B Analyt Technol Biomed Life Sci. 2023 May 15:1223:123715.) Article January 2023 Tissue Assessment of Therapeutic Responses to Neoadjuvant SCRT with and without Anit-CD40 Immunotherapy Sotigalimab (Sotiga) in Rectal Cancer ASCO GI Poster January 2023 Use of High-dimensional and Spatial Immune Profiling to Explore Sotigalimab (CD40 Agonist) Activation of Antigen Presenting Cells and T Cells in the Tumor Microenvironment in Patients with Esophageal/Gastroesophageal Junction Cancer ASCO GI Poster January 2023 Quantification of antibody–drug conjugate PYX-201 in rat and monkey plasma via ELISA and its application in preclinical studies (Bioanalysis. 2023 Jan;15(1):43-52.) Article «23456»